Cross Country Healthcare agreed on 6 May to be acquired by Knox Lane for $13.25 a share in an all-cash transaction valued at $437m.
Why Knox Lane is buying Cross Country Healthcare, Inc.
Cross Country chief executive Kevin Clark said Knox Lane brings direct sector expertise to help the company's next phase of growth while delivering immediate value to stockholders. Knox Lane said it would bring added strategic focus to the business's technology and customer relationships.
Deal terms and financing
The price was about 31% above Cross Country's closing price on 6 May and 45% above its 90-day volume-weighted average. The company keeps its name and becomes a platform company in Knox Lane's portfolio.
Regulatory approvals and timing
The deal needed stockholder and regulatory approvals. Cross Country completed the merger on 21 July 2026 and filed to deregister its shares.
Market context
Based in Boca Raton, Florida, Cross Country provides healthcare workforce solutions.
